DAXOR CORP DXR
Nasdaq · XNAS · stock · website · IPO 1983-07-25
DAXOR CORP insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Michel Robert J | Chief Financial Officer | 2026-06-23 | Grant | 12,000 | — |
| Feldschuh Michael Richard | Chief Executive Officer | 2026-06-23 | Grant | 30,000 | — |
| Feldschuh Jonathan Adam | Chief Scientific Officer | 2026-06-23 | Grant | 25,000 | — |
| Feldschuh Michael Richard | Chief Executive Officer | 2026-04-08 | Buy | 1,000 | $9.07 |
| Michel Robert J | Chief Financial Officer | 2026-03-31 | Buy | 1,000 | $9.90 |
| Jefferies John | Chief Medical Officer | 2026-03-20 | Buy | 3,656 | — |
| Jefferies John | Chief Medical Officer | 2026-03-20 | Buy | 2,285 | — |
Source: SEC EDGAR filings · CIK 0000027367 · as of 2011-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.